Cargando…
Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients
INTRODUCTION: Advances in genomic techniques have been valuable in guiding decisions regarding the treatment of early breast cancer (EBC) patients. These multigene assays include Oncotype DX, Prosigna, and Endopredict. There has generally been a tendency to overtreat or undertreat patients, and havi...
Autores principales: | Assi, Hazem I., Alameh, Ibrahim A., Khoury, Jessica, Abdul Halim, Nour, El Karak, Fadi, Farhat, Fadi, Berro, Juliett, Sbaity, Eman, Charafeddine, Maya, Tfayli, Arafat, Salem, Ziad, El Saghir, Nagi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719508/ https://www.ncbi.nlm.nih.gov/pubmed/33312202 http://dx.doi.org/10.1155/2020/9238084 |
Ejemplares similares
-
Fertility in Breast Cancer Survivors in the Middle East: A Retrospective Study
por: Assi, Hazem I., et al.
Publicado: (2020) -
Current Status and Future Perspectives of Immunotherapy in Middle-Income Countries: A Single-Center Early Experience
por: Bou Akl, Imad, et al.
Publicado: (2020) -
Improved Survival of Young Patients With Breast Cancer 40 Years and Younger at Diagnosis
por: El Saghir, Nagi S., et al.
Publicado: (2023) -
COVID-19 vaccination immune response in patients with solid organ and
haematologic malignancies: call for active monitoring
por: Chehade, Laudy, et al.
Publicado: (2021) -
Outcomes of Patients with Malignancy Admitted to the Intensive Care Units: A Prospective Study
por: Assi, Hazem I., et al.
Publicado: (2021)